FAITH WEINTRAUB: Open Payments
NPI 1386620052 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,074 in 53 payments from 29 companies in 2025. Trend: 2023 $653 · 2024 $682 · 2025 $1,074
Food & beverage: $1,074
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $165 |
| Daiichi Sankyo Inc. | 5 | $108 |
| Novartis Pharmaceuticals Corporation | 5 | $99 |
| TOLMAR, INC. | 4 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Gilead Sciences, Inc. | 3 | $52 |
| pharmaand GmbH | 3 | $50 |
| Stemline Therapeutics Inc. | 2 | $38 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $37 |
| EMD Serono, Inc. | 2 | $34 |
Products named: Enhertu, Rubraca, Nubeqa, Trodelvy, PLUVICTO, Orserdu, NERLYNX, ELIGARD.
Industry payments across NJ — which companies pay providers there.
